NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054288

Registered date:01/05/2024

A multi-institutional prospective observational study of incidence and risk factors for the development of osteosarcopenia in patients with unresectable pancreatic cancer receiving chemotherapy

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedPancreatic cancer
Date of first enrollment2024/03/01
Target sample size150
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeCumulative incidence of osteosarcopenia up to 12 months
Secondary OutcomeThe incidence of osteosarcopenia, the incidence of bone-related adverse events, the incidence of osteoporosis, the incidence of bone loss, the incidence of sarcopenia, the incidence of low trabecular bone score, overall survival, chemotherapy-induced adverse events, relative dose intensity, factors related to the incidence of osteosarcopenia (before chemotherapy, 6 and 12 months)

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaPatients undergoing chemotherapy for pancreatic cancer prior to obtaining informed consent. Patients deemed ineligible for the study

Related Information

Contact

public contact
Name Sho Ishikawa
Address 454 Shitsukawa, Toon, Ehime, Japan Japan 791-0295
Telephone 0899645111
E-mail ishikawa.sho.nu@ehime-u.ac.jp
Affiliation Ehime University Graduate School of Medicine Department of Gastroenterology and Metabology
scientific contact
Name Mitsuhito Koizumi
Address 454 Shitsukawa, Toon, Ehime, Japan Japan
Telephone 0899645111
E-mail koizumim@m.ehime-u.ac.jp
Affiliation Ehime University Graduate School of Medicine Department of Gastroenterology and Metabology